You have been keeping track of all of it.
In your head.

Lumyx Health is a physician-led platform being built to help women navigate perimenopause, menopause, and the years beyond — while helping clinicians provide more informed, connected care. It will bring symptoms, cycles, health history, laboratory results, treatments, and personal priorities into one view for women, while supporting clinicians with concise context and reviewed evidence. Lumyx is designed to strengthen, not replace, clinical judgment or the relationship between a woman and her clinician.

Lumyx is more than a symptom tracker, content library, chatbot, or one-size-fits-all menopause clinic. It will connect two experiences: women can build a clearer health story, and, with their authorization, clinicians can review a concise summary supported by trusted evidence. By connecting preparation, the visit, and follow-up, Lumyx will help women and clinicians use their time together more meaningfully, while closing the knowledge gap around midlife care for women.

Lumyx is being designed for women navigating perimenopause, menopause, and postmenopause — and for the clinicians and organizations that care for them. For women, it will look beyond hot flashes to sleep, mood, cognition, menstrual changes, sexual and urinary health, metabolism, bone and heart health, gynecologic concerns, and prevention. For clinicians and organizations, it will offer a clearer clinical picture, evidence-informed support, and a more useful starting point for care.

See the full picture. Lumyx will help women bring together symptoms, cycles, health history, treatments, selected laboratory results, priorities, and questions — so important details are easier to understand and less likely to be overlooked. Come prepared. Women can review and edit their information, then decide what to share. Clinicians can quickly see the concerns, patterns, and context that matter most, with relevant evidence to support — not replace — their clinical judgment. Stay connected over time. Lumyx will help women and clinicians follow symptoms, treatment response, decisions, education, and next steps, so each visit begins with a clearer understanding of what has changed.

Lumyx Health was founded and is led by a board-certified OB-GYN with more than a decade of experience in private practice and hospital care. A multidisciplinary team brings expertise in clinical care, product development, technology, design, privacy, and security. Lumyx grew from seeing women's midlife concerns fragmented across symptoms, specialists, and short visits. The team is building a clearer way for women and clinicians to see the full picture together.

Yes. Lumyx is being built to support the clinician you already know and trust. When available, you can choose whether to share a concise summary; your clinician will decide how to use it within your care.

Lumyx is currently in development. Joining the waitlist is the fastest way to hear when features become available, and early members may be invited to try the platform ahead of general access.

No. Lumyx will not independently diagnose, prescribe, or choose treatment. It will organize the information you provide, offer education from reviewed sources, and help you prepare questions. Diagnosis and treatment decisions remain with you and an appropriately licensed healthcare professional.

Lumyx is being designed to keep you in control of your information. You can review or correct it and choose what to share and with whom. Personal tracking will remain separate from information you authorize for clinical use, with permissions and privacy practices explained clearly.

With the woman's authorization, Lumyx may give clinicians a concise view of symptoms, cycles, relevant history, medications and treatments, priorities, and changes over time, with efficient access to reviewed evidence and clinical care pathways. The goal is a more productive visit without replacing the clinician's assessment, documentation, or judgment.

AI will have a defined, assistive role: organizing patient-reported information, identifying patterns for review, retrieving approved content, and summarizing reviewed evidence. It will not independently diagnose, prescribe, invent guidance, change patient information silently, or make treatment decisions. Important outputs should be labeled, editable, traceable to their sources, and open to clinician review; urgent or high-risk pathways will not rely on generative AI alone.

Lumyx is not offering a finished, one-size-fits-all rollout. Current collaboration focuses on listening, responsible co-design, research, workflow testing, education, and planning for future pilots. Organizations can explore a defined opportunity shaped by their population, clinical environment, and governance requirements.

Privacy, safety, and governance are being built in from the start. Lumyx is designed around patient-controlled sharing, clear clinical boundaries, reviewable evidence, clinician judgment, data minimization, and appropriate privacy and security controls. Relevant legal, regulatory, clinical-safety, privacy, and security requirements must be implemented and assessed before deployment. Lumyx will make compliance claims only when the necessary people, processes, technology, and data flows are in place.